40 results on '"Breyholz, Hans-Jörg"'
Search Results
2. Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer.
3. Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
4. The MMP inhibitor ( R)-2-( N-benzyl-4-(2-[ 18F]fluoroethoxy)phenylsulphonamido)- N-hydroxy-3-methylbutanamide: Improved precursor synthesis and fully automated radiosynthesis
5. Translational Imaging of the Fibroblast Activation Protein (FAP) Using the New Ligand [68Ga]Ga-OncoFAP-DOTAGA
6. Multimodal Imaging Reveals Temporal and Spatial Microglia and Matrix Metalloproteinase Activity after Experimental Stroke
7. PET-compatible endothelin receptor radioligands: Synthesis and first in vitro and in vivo studies
8. Synthesis, in vitro pharmacology and biodistribution studies of new PD 156707-derived ET A receptor radioligands
9. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators
10. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo
11. Synthesis and Preliminary In Vitro and In Vivo Evaluation of Thiirane‐Based Slow‐Binding MMP Inhibitors as Potential Radiotracers for PET Imaging
12. Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases
13. Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
14. A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies
15. Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer.
16. Efficient synthesis of a fluorine-18 labeled biotin derivative
17. A New Class of Highly Potent Matrix Metalloproteinase Inhibitors Based on Triazole-Substituted Hydroxamates: (Radio)Synthesis and in Vitro and First in Vivo Evaluation
18. A New Generation of Radiofluorinated Pyrimidine-2,4,6-triones as MMP-Targeted Radiotracers for Positron Emission Tomography
19. Radiofluorinated Pyrimidine‐2,4,6‐triones as Molecular Probes for Noninvasive MMP‐Targeted Imaging
20. Synthesis and Evaluation of a Novel Hydroxamate Based Fluorescent Photoprobe for Imaging of Matrix Metalloproteinases
21. Synthesis and Evaluation of a Novel Fluorescent Photoprobe for Imaging Matrix Metalloproteinases
22. Novel Fluorinated Derivatives of the Broad-Spectrum MMP Inhibitors N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as Potential Tools for the Molecular Imaging of Activated MMPs with PET
23. 5-Pyrrolidinylsulfonyl Isatins as a Potential Tool for the Molecular Imaging of Caspases in Apoptosis
24. Synthesis, in vitro pharmacology and biodistribution studies of new PD 156707-derived ETA receptor radioligands
25. Synthesis of an18F-labelled high affinityβ1-adrenoceptor PET radioligand based on ICI 89,406
26. C-5-Disubstituted Barbiturates as Potential Molecular Probes for Noninvasive Matrix Metalloproteinase Imaging
27. Synthesis of (R)- and (S)-[O-methyl-11C]N-[2-[3-(2-cyano-phenoxy)-2-hydroxy-propylamino]-ethyl]-N′-(4-methoxy-phenyl)-urea as candidate high affinityβ1-adrenoceptor PET radioligands
28. Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo
29. New Tandem Ring Enlargements of Bicyclo[3.3.0]octanes to Bicyclo[5.5.0]dodecanes and Subsequent Conversions into Tricyclo[5.5.0.0.2,9]dodecane and Tricyclo[5.5.0.02,10]dodecane Derivatives
30. A New Class of HighlyPotent Matrix MetalloproteinaseInhibitors Based on Triazole-Substituted Hydroxamates: (Radio)Synthesisand in Vitro and First in Vivo Evaluation.
31. A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies
32. Synthesis of an 18F-labelled high affinity β1-adrenoceptor PET radioligand based on ICI 89,406.
33. Synthesis of ( R)- and ( S)-[ O-methyl-11C] N-[2-[3-(2-cyano-phenoxy)-2-hydroxy-propylamino]-ethyl]- N′-(4-methoxy-phenyl)-urea as candidate high affinity β1-adrenoceptor PET radioligands.
34. Synthesis of an 18F‐labelled high affinity β1‐adrenoceptor PET radioligand based on ICI 89,406
35. Synthesis of (R)‐ and (S)‐[O‐methyl‐11C]N‐[2‐[3‐(2‐cyano‐phenoxy)‐2‐hydroxy‐propylamino]‐ethyl]‐N′‐(4‐methoxy‐phenyl)‐urea as candidate high affinity β1‐adrenoceptor PET radioligands
36. The MMP inhibitor (R)-2-(N-benzyl-4-(2-[18F]fluoroethoxy)phenylsulphonamido)-N-hydroxy-3-methylbutanamide: Improved precursor synthesis and fully automated radiosynthesis
37. Synthesis, in vitro pharmacology and biodistribution studies of new PD 156707-derived ETA receptor radioligands
38. Initial Results of 68 Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer.
39. Correlation of Intraprostatic Tumor Extent with ⁶⁸Ga-PSMA Distribution in Patients with Prostate Cancer.
40. A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.